FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sharon Hassin-Baer

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Procedures

Anatomy

Brain

Geographic Areas

Israel

Co-author Network

Publications

TOP 3
Gilad Yahalom; Hofit Cohen; Lilach Ephraty; Noa Molshatzki; Rakefet Tsabari; Sharon Hassin-Baer
Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic Acid: early versus late diagnosis.
Sari Maril; Oren S Cohen; Sharon Hassin-Baer; Rachel Tomer
Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
Andreea Nissenkorn; Michal Tzadok; Sharon Hassin-Baer; Sheera F Lerman; Yonit Banet Levi; Bruria Ben-Zeev
Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sharon Hassin-Baer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gilad Yahalom; Hofit Cohen; Lilach Ephraty; Noa Molshatzki; Rakefet Tsabari; Sharon Hassin-Baer
Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic Acid: early versus late diagnosis.
Clinical neuropharmacology 2013;36(3):78-83.
2013: Sari Maril; Oren S Cohen; Sharon Hassin-Baer; Rachel Tomer
Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.
Neuropsychologia 2013;51(5):818-24.
2013: Andreea Nissenkorn; Michal Tzadok; Sharon Hassin-Baer; Sheera F Lerman; Yonit Banet Levi; Bruria Ben-Zeev
Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
Journal of child neurology 2013;28(2):155-60.
2012: Gilad Yahalom; Oren S Cohen; Eitan Friedman; Rivka Inzelberg; Natalie Kaplan; Amos D Korczyn; Evgenia Kozlova; Saharon Rosset; Aya Vituri; Sharon Hassin-Baer
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
Parkinsonism & related disorders 2012;18(9):1039-41.
2012: Oren S Cohen; Noa Molshatzki; Zeev Nitsan; David Tanne; Eli Vakil; Sharon Hassin-Baer
The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
Journal of geriatric psychiatry and neurology 2012;25(2):71-7.
2012: Michal Benkler; Miri Blank; Joab Chapman; Oren S Cohen; Maya Damianovich; Sharon Hassin-Baer; Amalia Levy; Samuel-Datum Moscavitch; Oscar-Danilo Ortega-Hernandez; Nancy Agmon-Levin; Martine Szyper-Kravitz; Yehuda Shoenfeld
Immunology, autoimmunity, and autoantibodies in Parkinson's disease.
Clinical reviews in allergy & immunology 2012;42(2):164-71.
2012: Rivka Inzelberg; N Kaplan; E Kozlova; A Mory; Z Nitsan; E Schechtman; I Schlesinger; O Tunkel; J Aharon-Peretz; O S Cohen; E Dagan; R Djaldetti; L Ephraty; T Fixler Mehr; E Friedman; R Gershoni-Baruch; L Inzelberg; Sharon Hassin-Baer
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.
Neurology 2012;78(11):781-6.
2011: Sharon Hassin-Baer; Oren S Cohen; Lilach Efrati; Evgenia Kozlova; Irena Molchadski; Zeev Nitzan; Olga Tunkel; Amos D Korczyn
Gender effect on time to levodopa-induced dyskinesias.
Journal of neurology 2011;258(11):2048-53.
2011: Rivka Inzelberg; I Liphshiz; Eldad Melamed; R Milo; J M Rabey; A Reches; M Schwartz; H Trau; J Aharon-Peretz; Samih Badarny; Micha Barchana; Oren S Cohen; Ruth Djaldetti; Cheryl Fitzer-Attas; L Gilead; Sharon Hassin-Baer; M Huberman; Nir Giladi
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(8):1199-207.
2011: Sharon Hassin-Baer; Oren S Cohen; Eli Vakil; Noa Molshazki; Ben-Ami Sela; Zeev Nitsan; Joab Chapman; David Tanne
Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(4):539-43.
2011: Sharon Hassin-Baer; Nobutaka Hattori; Oren S Cohen; Magdalena Massarwa; Simon Israeli-Korn; Rivka Inzelberg
Phenotype of the 202 adenine deletion in the parkin gene: 40 years of follow-up.
Movement disorders : official journal of the Movement Disorder Society 2011;26(4):719-22.
2011: Jens Schuster; Jimmy Sundblom; Ann-Charlotte Thuresson; Sharon Hassin-Baer; Thomas Klopstock; Martin Dichgans; Oren S Cohen; Raili Raininko; Atle Melberg; Niklas Dahl
Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms.
Neurogenetics 2011;12(1):65-72.
2011: I Molchadski; Amos D Korczyn; O S Cohen; Aviva Katzav; Z Nitzan; Joab Chapman; Sharon Hassin-Baer
The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia.
Acta neurologica Scandinavica 2011;123(2):117-21.
2009: Sharon Hassin-Baer; Yael Laitman; Esther Azizi; Irena Molchadski; Gilli Galore-Haskel; Frida Barak; Oren S Cohen; Eitan Friedman
The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.
Journal of neurology 2009;256(3):483-7.
2009: Omer Porat; Oren S Cohen; Roseline Schwartz; Sharon Hassin-Baer
Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 2009;21(4):398-405.
2007: Oren S Cohen; Sharon Hassin-Baer; Roberto Spiegelmann
Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia.
Parkinsonism & related disorders 2007;13(8):541-4.
2007: Sharon Hassin-Baer; Yair Levy; Pnina Langevitz; Sasson Nakar; Michael Ehrenfeld
Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.
Clinical rheumatology 2007;26(5):743-7.
2007: Lilach Ephraty; Omer Porat; David Israeli; Oren S Cohen; Olga Tunkel; Shinar Yael; Yasuko Hatano; Nobutaka Hattori; Sharon Hassin-Baer
Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations.
Movement disorders : official journal of the Movement Disorder Society 2007;22(4):566-9.
2007: Oren S Cohen; Eli Vakil; David Tanne; Zeev Nitsan; Roseline Schwartz; Sharon Hassin-Baer
Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2007;20(1):68-72.
2006: Sharon Hassin-Baer; Oren Cohen; Eli Vakil; Ben-Ami Sela; Zeev Nitsan; Roseline Schwartz; Joab Chapman; David Tanne
Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.
Clinical neuropharmacology 2006;29(6):305-11.
2005: Zvi Israel; Sharon Hassin-Baer
Subthalamic stimulation for Parkinson's disease.
The Israel Medical Association journal : IMAJ 2005;7(7):458-63.
2005: Sharon Hassin-Baer; Esther Scheuer; Aron S Buchman; Izhak Jacobson; Bruria Ben-Zeev
Botulinum toxin injections for children with excessive drooling.
Journal of child neurology 2005;20(2):120-3.
2005: Alexander Lossos; Dov Soffer; Bettina Steiner-Birmanns; Sharon Hassin-Baer; Menachem Sadeh; Michal Sagi; Eduard Linetski; Oded Abramsky; Zohar Argov; Hanna Rosenmann
Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy.
European neurology 2005;53(2):55-9.
2004: Yasuko Hatano; Kenichi Sato; B Elibol; Hiroyo Yoshino; Yasuhiro Yamamura; Vincenzo Bonifati; Hitoshi Shinotoh; Masato Asahina; S Kobayashi; A R Ng; R L Rosales; Sharon Hassin-Baer; Y Shinar; Chin-Song Lu; H C Chang; Yah-Huei Wu Chou; F Belgin Ataç; Tomonori Kobayashi; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations.
Neurology 2004;63(8):1482-5.
2004: Leo Verhagen Metman; Brian Myre; Nicolaas Verwey; Sharon Hassin-Baer; Jean Arzbaecher; Diane Sierens; Roy A E Bakay
Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):1079-1084.
2004: Yasuko Hatano; Yuanzhe Li; Kenichi Sato; Shuichi Asakawa; Yasuhiro Yamamura; Hiroyuki Tomiyama; Hiroyo Yoshino; Masato Asahina; Susumu Kobayashi; Sharon Hassin-Baer; Chin-Song Lu; Arlene R Ng; Raymond L Rosales; Nobuyoshi Shimizu; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
Novel PINK1 mutations in early-onset parkinsonism.
Annals of neurology 2004;56(3):424-7.
2004: Sharon Hassin-Baer; Eilon D Kirson; Lester Shulman; Aron S Buchman; Hanna Bin; Musa Hindiyeh; Lea Markevich; Ella Mendelson
Stiff-person syndrome following West Nile fever.
Archives of neurology 2004;61(6):938-41.
2003: Ruth Djaldetti; Nir Giladi; Sharon Hassin-Baer; Herzel Shabtai; Eldad Melamed
Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study.
Clinical neuropharmacology 2003;26(6):322-6.
2001: D Tanne; Sharon Hassin-Baer
Neurologic manifestations of the antiphospholipid syndrome.
Current rheumatology reports 2001;3(4):286-92.
2001: Sharon Hassin-Baer; Pinkhas Sirota; Amos D Korczyn; Therese A Treves; B Epstein; Herzel Shabtai; T Martin; Y Litvinjuk; Nir Giladi
Clinical characteristics of neuroleptic-induced parkinsonism.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(11):1299-308.
2000: Y C Cohen; Sharon Hassin-Baer; Liraz Olmer; R Barishev; Y Goldhammer; Laurence Freedman; B Mozes
MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(5):355-61.
1999: Sharon Hassin-Baer; Anat Bar-Shira; Susan Gilad; Yaron Galanty; R Khosravi; Alexander Lossos; Nir Giladi; R Weitz; Bruria Ben-Zeev; Y Goldhammer; Yosef Shiloh
Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia.
Journal of neurology 1999;246(8):716-9.
1999: Israel Steiner; O Cohen; Ronen R Leker; B Rubinovitch; R Handsher; Sharon Hassin-Baer; D H Gilden; Menachem Sadeh
Subacute painful lumbosacral polyradiculoneuropathy in immunocompromised patients.
Journal of the neurological sciences 1999;162(1):91-3.
1998: Anat Achiron; uri gabbay; Ronit Gilad; Sharon Hassin-Baer; Yoram Barak; M Gornish; A Elizur; Y Goldhammer; Ida Sarova-Pinhas
Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.
Neurology 1998;50(2):398-402.